Welcome to the e-CCO Library!
Best abstract: Patient-relevant endpoints in Inflammatory Bowel Diseases - Have changes occured in Germany over the past twelve years?
Webcast - ECCO 2015 Barcelona Congress - Scientific Session 5: Delivering quality to the patients (Keywords: anti-TNF, biologic treatment, colectomy, disease outcome, IBD, mortality)
Stallmach Andreas
Best abstract: Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with Crohn’s Disease: Results from the UNITI-1 and UNITI-2 studies
Webcast - ECCO 2016 Amsterdam Congress - Scientific session 11: Right time, right drug, right strategy (Keywords: CD, pharmacokinetics, ustekinumab, exposure response)
Omoniyi Adedokun
Best abstract: Predicting short and medium-term efficacy of the biosimilar infliximab: Trough levels/ADAs or clinical/biochemical markers play a more important role?
Webcast - ECCO 2016 Amsterdam Congress - Scientific session 1: Cell therapy: Ready for clinical practice? (Keywords: anti-TNF, biologic treatment, CRP, disease outcome, IBD, infliximab, monitoring, trough levels, therapeutic drug monitoring)
Petra Golovics
Best abstract: Prep1: A new player in the development of IBD-associated fibrosis
Webcast - ECCO 2013 Vienna Congress - Scientific session 2: Preventing progression in IBD
Silvia D'Alessio
Best abstract: Prevalence of anaemia in patients with Inflammatory Bowel Disease during the first ten years from diagnosis- results from a population-based inception cohort, the IBSEN Study
Webcast - ECCO 2013 Vienna Congress - Scientific session 5: Reproduction and IBD
Marte Lie Hoivik
Best abstract: Prolonged deep remission of ileocolonic Crohn’s Disease following Autologous Haemopoetic stem cell transplantation, presented on behalf of all the ASTIC Trialists
Webcast - ECCO 2015 Barcelona Congress - Scientific Session 7: ECCO Fellowships and Grants (Keywords: autologous stem cell transpl., CD)
Hawkey Chris
Best abstract: Results of ANDANTE, a randomised clinical study with an anti-IL6 antibody (PF-04236921) in subjects with Crohn’s Disease who are anti-TNF inadequate responders
Webcast - ECCO 2016 Amsterdam Congress - Scientific session 5: Challenging dogmas – from clinical trials to clinical practice (Keywords: Clinical Study, CD, IBD, anti TNF, Therapy)
Silvio Danese
Best abstract: Risk factors for colorectal neoplasia in Ulcerative Colitis: Results from the largest and longest-running colonoscopic surveillance programme
Webcast - ECCO 2016 Amsterdam Congress - Scientific session 4: Viruses and IBD (Keywords: cancer, cancer in IBD, colorectal cancer surveillance, disease outcome, endoscopic assessment, IBD, UC)
Chang Ho Ryan Choi
Best abstract: Risk factors for Inflammatory Bowel Disease associated colorectal carcinoma
Webcast - ECCO'11 Dublin Congress
Maurice Lutgens
Best abstract: Risk of colectomy in patients with ulcerative colitis under thiopurine treatment. Study of prevalence and predictive factors. ENEIDA project
Webcast - ECCO'12 Barcelona Congress
Alex Canas-Ventura
Best abstract: SPARC modifies colonic tissue healing and inflammation by regulating collagen and MMP expression
Webcast - ECCO'12 Barcelona Congress
Ian Lawrance
Best abstract: Status of ER stress and autophagy in Crohn’s Disease: From genetics to functional read-outs
Webcast - ECCO 2014 Copenhagen Congress - Scientific session 5: Fibrosis as a complication: Best abstract: Status of ER stress and autophagy in Crohn’s Disease: From genetics to functional read-outs (Keywords: autophagy, genetic, IBD, CD, ER stress)
Kris Nys
Best abstract: Steroid-free remission in adalimumab-treated paediatric patients with moderately to severely active Crohns Disease in the IMAgINE 1 trial
Webcast - ECCO 2014 Copenhagen Congress - Scientific session 10: Colitis under the microscope: Best abstract: Steroid-free remission in adalimumab-treated paediatric patients with moderately to severely active Crohns Disease in the IMAgINE 1 trial (Keywords: adalimumab, adolescents, disease activity)
Anne Griffiths
Best abstract: The cost of investigations and medical treatment including biological therapy in a European inception cohort from the biological era - An ECCO-EpiCom study
Webcast - ECCO 2014 Copenhagen Congress - Scientific session 3: Cost of therapy, burden of care : Best abstract: The cost of investigations and medical treatment including biological therapy in a European inception cohort from the biological era - An ECCO-EpiCom study (Keywords: 5-ASA, adalimumab, anti-TNF, AZA, biologic treatment, ECCO, IBD, CD, UC)
Johan Burisch
Best abstract: The GCN2/eIF2alpha/ATF4 signaling pathway is necessary for autophagy response to infection with Crohn's Disease-associated adherent-invasive Escherichia coli1>
Webcast - ECCO 2014 Copenhagen Congress - Scientific session 1: Neglected cells as potential targets: Best abstract: The GCN2/eIF2alpha/ATF4 signaling pathway is necessary for autophagy response to infection with Crohn's Disease-associated adherent-invasive Escherichia coli1> (Keywords: autophagy, CD, adherent-invasive Escherichia coli, amino acid stress)
Hang Nguyen, Jessica Carrière, Guillaume Dalmasso, Alain Bruhat, Arlette Darfeuille-Michaud
Best abstract: The quality of care for inpatients with Inflammatory Bowel Disease in the UK over a six year period
Webcast - ECCO 2013 Vienna Congress - Scientific Session 9: Course and treatment of IBD in the elderly
Laith Alrubaiy, Ian Arnott, Aimee Protheroe, Michael Roughton, Richard Driscoll, John Williams
Best abstract: The TOPPIC trial: A randomised, double-blind parallel group trial of mercaptopurine vs placebo to prevent recurrence of Crohn’s Disease following surgical resection in 240 patients
Webcast - ECCO 2016 Amsterdam Congress - Scientific session 10: Surgical and endoscopic FAQs in IBD (Keywords: mercaptopurine, CD, postoperative)
Jack Satsangi
Best abstract: TLR4 signaling activates the WNT pathway in a mouse model of colitis-associated neoplasia
Webcast - ECCO'12 Barcelona Congress
Rebeca Santaolalla
Best abstract: TNF and MDP induce epithelial-to-mesenchymal transition in human intestinal cells: Implications for the pathogenesis of Crohn's disease-associated fistulae and the use of anti-TNF antibodies
Webcast - ECCO'12 Barcelona Congress
Michael Scharl
Best abstract: Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe Ulcerative Colitis: A phase 2 randomized placebo-controlled study
Webcast - ECCO 2014 Copenhagen Congress - Scientific session 4: Tomorrow’s therapy: Best abstract: Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe Ulcerative Colitis: A phase 2 randomized placebo-controlled study
Silvio Danese